Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen |
| |
Authors: | Hans-Martin Kauffmann Dietrich Keppler Timothy W. Gant Dieter Schrenk |
| |
Affiliation: | (1) Food Chemistry and Environmental Toxicology, University of Kaiserslautern, Erwin-Schroedinger-Strasse, D-67663 Kaiserslautern, Germany, DE;(2) Deutsches Krebsforschungszentrum, Division of Tumor Biochemistry, D-69120 Heidelberg, Germany, DE;(3) MRC Toxicology Unit, University of Leicester, Leicester, LE1 9HN, UK, GB |
| |
Abstract: | The multidrug resistance protein 2 (Mrp2) also called canalicular multidrug resistance protein (cMrp) or canalicular multispecific organic anion transporter (cMoat) is a transmembrane export pump located at the canalicular domain of hepatocytes. Mrp2 transports a broad spectrum of organic anions including glucuronides, glutathione conjugates, and organic sulphates into bile. Based on previous observations in rat hepatocytes, the inducibility of mrp2 gene expression in primate liver was investigated in rhesus monkeys treated with tamoxifen or rifampicin. It was found that treatment with tamoxifen (25 mg/kg per day; over 7 days) or rifampicin (15 mg/kg per day; over 7 days) leading to an induction of cytochrome P450 3A4, resulted in a strong increase in mrp2 mRNA in the liver of male and female rhesus monkeys. On the protein level, tamoxifen also was a highly effective inducer, while rifampicin showed some inducing effect in a female and was inactive in a male monkey. In sections of paraffin-embedded liver tissue, immunofluorescence staining confirmed the results of Western blot analysis. Induced Mrp2 was localized to the canalicular domain of the hepatocytes. In conclusion, our data show inducibility of mrp2 gene expression in the liver of primates which may represent an adaptive response aimed at the enhanced biliary elimination of the inducing drugs and/or their metabolites. Received: 8 June 1998 / Accepted: 7 September 1998 |
| |
Keywords: | Induction Monkey liver Multidrug resistance protein 2 Rifampicin Tamoxifen |
本文献已被 SpringerLink 等数据库收录! |
|